-
Bazedoxifene as a Potent Antimalarial: SERM Repurposing Insi
2026-06-11
Sudhakar et al. demonstrate that bazedoxifene, a third-generation selective estrogen receptor modulator, shows potent antimalarial activity by inhibiting Plasmodium falciparum erythrocytic development and blocking hemozoin formation. This work highlights the promise of clinical SERMs as candidates for drug repurposing against malaria, with mechanistic implications for related molecules such as tamoxifen.
-
Combining eIF4F, AKT1, and EZH2 Inhibition in BRAF-Mutant Me
2026-06-10
This study demonstrates that combinatorial inhibition of the eIF4F complex, AKT1, and EZH2 markedly overcomes resistance mechanisms in BRAFV600E-mutant A375 melanoma cells. The results provide mechanistic insights into adaptive survival pathways and inform multi-targeted therapeutic strategies for melanoma.
-
Fluorinated CXCR4 Inhibition in Colorectal Cancer: Insights
2026-06-10
Khorramdelazad et al. introduce A1, a novel fluorinated CXCR4 inhibitor, demonstrating superior antitumor efficacy over AMD3100 in colorectal cancer models. Their integrative in silico, in vitro, and in vivo approach highlights A1's enhanced binding, immune modulation, and tumor suppression, underscoring the evolving role of CXCR4-targeted agents in cancer metastasis inhibition.
-
Berberrubine Chloride: Protocols and Workflows for Cancer Re
2026-06-09
Berberrubine chloride stands out as a multi-pathway, DMSO-soluble isoquinoline alkaloid for advanced cancer and metabolic disease models. This article translates the latest mechanistic insights and protocol parameters into actionable steps for maximizing reproducibility and mechanistic clarity in the lab.
-
Reliable Neuroprotection: ω-Agatoxin IVA TFA (SKU C8722) in
2026-06-09
This article examines how ω-Agatoxin IVA TFA (SKU C8722) addresses common challenges in neuronal calcium assays and synaptic transmission research. Drawing on peer-reviewed structure-activity insights and validated protocols, it guides researchers on achieving reproducibility and high specificity in P/Q-type calcium channel blockade. Practical Q&A scenarios highlight workflow optimization and product selection for reliable, quantitative results.
-
2'3'-cGAMP (Sodium Salt): Optimizing STING Pathway Activatio
2026-06-08
2'3'-cGAMP (sodium salt) empowers precise activation of the cGAS-STING pathway for robust type I interferon induction, facilitating advanced immunotherapy and antiviral research. This guide delivers actionable workflows, troubleshooting strategies, and highlights innovations from recent nanoparticle delivery studies, ensuring superior experimental outcomes.
-
Optimizing CYP2C19 Substrate Assays: (S)-Mephenytoin in Next
2026-06-08
(S)-Mephenytoin is a gold-standard CYP2C19 substrate, but recent advances in human intestinal organoid models are redefining its optimal use in pharmacokinetic and cytochrome P450 metabolism studies. Discover protocol insights, practical limitations, and the latest evidence to elevate your in vitro research.
-
JSH-23: Applied NF-κB Inhibitor Workflows for Inflammation R
2026-06-07
JSH-23 enables precision dissection of NF-κB-driven inflammation in both cell and animal models, offering reproducible control over cytokine signaling. Its robust solubility and selective inhibition of p65 make it an indispensable tool for translational studies targeting inflammatory pathways.
-
Erastin as a Ferroptosis Inducer: Applied Workflows & Innova
2026-06-06
Erastin empowers targeted ferroptosis research by exploiting RAS/BRAF-mutant tumor vulnerabilities and enabling next-generation immune-oncology strategies. This article delivers hands-on protocol guidance, troubleshooting, and practical insights inspired by landmark discoveries linking ferroptosis to antigen presentation and checkpoint therapy efficacy.
-
Malate ((S)-2-hydroxysuccinic acid) in TCA Cycle Research
2026-06-05
Malate ((S)-2-hydroxysuccinic acid) is a pivotal TCA cycle intermediate, enabling researchers to dissect mitochondrial metabolism, redox shuttling, and immune-metabolic crosstalk in vitro and in vivo. APExBIO’s malate (CAS 97-67-6) offers high solubility and batch consistency for advanced metabolic flux, enzyme modulation, and immunometabolism assays.
-
Dehydroabietic Acid: Dual PPAR-α/γ Agonist for Metabolic Res
2026-06-05
Dehydroabietic acid empowers researchers with precise dual PPAR-α/γ agonism for advanced modeling of lipid metabolism and insulin sensitivity. This guide delivers practical workflows, troubleshooting strategies, and key insights from recent metabolic research to maximize success in metabolic disorder studies.
-
Erastin as a Ferroptosis Inducer: Protocols and Innovations
2026-06-04
Erastin is redefining ferroptosis research by enabling precise, reproducible induction of iron-dependent cell death in RAS/BRAF-mutant models. This article bridges advanced workflows, troubleshooting insights, and the latest findings to help investigators unlock new avenues in cancer biology and oxidative stress studies.
-
PDHA1 Succinylation Modulates Immunity in Cholangiocarcinoma
2026-06-04
This study reveals that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma tumors drives metabolic reprogramming, leading to α-ketoglutaric acid accumulation and suppression of macrophage antigen presentation. The findings identify a metabolic-immune axis that contributes to immune evasion and chemoresistance, offering new targets for therapeutic intervention.
-
KX2-391 dihydrochloride: Protocols and Innovations in Oncolo
2026-06-03
KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) is a dual-mechanism small molecule that advances both cancer and antiviral research through potent Src kinase and tubulin inhibition. Explore how practical workflows leverage its unique activities for translational breakthroughs, with troubleshooting tips and data-backed guidance.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-06-03
This study demonstrates that naturally occurring angiotensin peptides, including specific C- and N-terminal fragments, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide new insight into the interplay between the renin–angiotensin system and viral pathogenesis, suggesting potential avenues for research into hypertension, cardiovascular disease, and COVID-19 mechanisms.